Unhealthy Pharmaceutical Regulation

Courtney Davis · John M. Abraham

99 citations0/0 files storedPalgrave Macmillan UK eBooks

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Healthcare Regulation Biomedical Ethics and Regulation

Abstract

This is the first book to examine how effectively American and supranational EU governments have regulated innovative pharmaceuticals during the last 30 years regarding public health. It explains why

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 99 citations exist upstream.

Cited by

2019Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis 2015Promissories and pharmaceutical patents: agencing markets through public narratives 2018How expected outcomes, stakeholders, and institutions influence corporate social responsibility at different levels of large basic needs firms 2023The reputational dividends of collaborating with a highly reputable agency: The case of interagency collaboration between the U.S. FDA and its domestic partner agencies 2024Private consulting firms’ intervention in public health policymaking: An exploratory review

Imported from OpenAlex (CC0) — nothing here is generated.